-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19

Benzinga·06/24/2026 14:45:02
Listen to the news
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $18 to $19.